- Others
- Thursday, 19 Mar 2020
Oil surges up after 3 days plunge but coronavirus restraints gains
Oil prices rose nearly 3% on Thursday after a three-day selloff sparked by the spread of the coronavirus and a market share battle between Saudi Arabia and Russia drove them to their lowest in almost two decades.
Benchmark Brent, which has lost half its value in less than two weeks, got some respite as investors across financial markets assessed the impact of massive central bank stimulus measures.
Brent crude LCOc1 was up 72 cents, or 3%, to $25.60 a barrel by 1225 GMT, after plunging to $24.52 on Wednesday, its lowest level since 2003.
West Texas Intermediate (WTI) crude CLc1 gained $1.57, or 7.8%, to $21.94 after dropping nearly 25% in the previous session to an 18-year low.
But analysts said gains were likely to be temporary, as tumbling demand was compounded by the collapse this month of a deal between OPEC, Russia and others to curb supply.
Saudi Arabia, de facto leader of OPEC, has since kicked off a price war with Russia as it plans to increase supply to a record-high 12.3 million barrels per day (bpd) for months.
The drop in demand, particularly in transportation, is also leading to a rapidly growing glut in refined products such as jet fuel and gasoline.
Related Industry Updates
The Violence Usually Begins After Dusk Falls
Nov 11, 2019
Having Trouble Finding Hand Sanitizer? You're Not Alone! New Retail Sales Data from SPINS Points to a Sharp Increase in Consumer Spending on Wellness Focused Products, Trend Expected to Continue
Mar 11, 2020
Azelio Signs a MoU With Trimark Associates in the US for Energy Storage Projects Across North America
Jun 24, 2020
Massive U.S. fiscal response to nurse the economy through the coronavirus crisis
Apr 08, 2020
WPX ENERGY ACCELERATES 5-YEAR VISION WITH OPPORTUNISTIC TRANSACTION
Dec 16, 2019
North America Biopharmaceutical Contract Manufacturing Market 2020-2027| Types, Applications, Regional Analysis and Key Companies Involved are Lonza Group, Abbvie Inc,WuXi Biologics, Thermo Fisher Scientific
Oct 20, 2020
New COVID-19 Clinical Trial Announced To Treat over 90% Of Patients With Underlying Medical Conditions
Apr 22, 2020